140 related articles for article (PubMed ID: 10846563)
1. Expression of classical protein kinase C subspecies in non-neoplastic lymphocytes and non-Hodgkin's lymphomas: an immunohistochemical study.
Hojo H; Morimura Y; Abe M; Wakasa H
Pathol Int; 1996 Feb; 46(2):148-54. PubMed ID: 10846563
[TBL] [Abstract][Full Text] [Related]
2. The leukocyte semaphorin CD100 is expressed in most T-cell, but few B-cell, non-Hodgkin's lymphomas.
Dorfman DM; Shahsafaei A; Nadler LM; Freeman GJ
Am J Pathol; 1998 Jul; 153(1):255-62. PubMed ID: 9665486
[TBL] [Abstract][Full Text] [Related]
3. Preferential expression of the mucosal homing receptor integrin alpha 4 beta 7 in gastrointestinal non-Hodgkin's lymphomas.
Drillenburg P; van der Voort R; Koopman G; Dragosics B; van Krieken JH; Kluin P; Meenan J; Lazarovits AI; Radaszkiewicz T; Pals ST
Am J Pathol; 1997 Mar; 150(3):919-27. PubMed ID: 9060830
[TBL] [Abstract][Full Text] [Related]
4. CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation.
Bellan C; De Falco G; Lazzi S; Micheli P; Vicidomini S; Schürfeld K; Amato T; Palumbo A; Bagella L; Sabattini E; Bartolommei S; Hummel M; Pileri S; Tosi P; Leoncini L; Giordano A
J Pathol; 2004 Aug; 203(4):946-52. PubMed ID: 15258998
[TBL] [Abstract][Full Text] [Related]
5. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
Nguyen PL; Harris NL; Ritz J; Robertson MJ
Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of neoplastic and reactive cell proliferation in non-Hodgkin's lymphomas linked to patient survival.
Ffrench M; Magaud JP; Ffrench P; Berger F; Devaux Y; Duhaut P; Shen N; Coiffier B; Bryon PA
Am J Clin Pathol; 1994 Apr; 101(4):413-20. PubMed ID: 8160629
[TBL] [Abstract][Full Text] [Related]
7. Bcl-2 oncoprotein is widespread in lymphoid tissue and lymphomas but its differential expression in benign versus malignant follicles and monocytoid B-cell proliferations is of diagnostic value.
Wang T; Lasota J; Hanau CA; Miettinen M
APMIS; 1995 Sep; 103(9):655-62. PubMed ID: 7488387
[TBL] [Abstract][Full Text] [Related]
8. Expression of cyclin D2 and D3 in lymphoid lesions.
Teramoto N; Pokrovskaja K; Szekely L; Polack A; Yoshino T; Akagi T; Klein G
Int J Cancer; 1999 May; 81(4):543-50. PubMed ID: 10225442
[TBL] [Abstract][Full Text] [Related]
9. Reed-Sternberg-like cells in low-grade lymphomas are transformed neoplastic cells of B-cell lineage.
Shin SS; Ben-Ezra J; Burke JS; Sheibani K; Rappaport H
Am J Clin Pathol; 1993 Jun; 99(6):658-62. PubMed ID: 8322699
[TBL] [Abstract][Full Text] [Related]
10. Expression of enolases in T cell tumors and Hodgkin's disease.
Oka K; Mori N; Haimoto H; Kato K
Lab Invest; 1990 Dec; 63(6):792-7. PubMed ID: 2255187
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of E2F-1 in non-Hodgkin's lymphomas: a survey of 124 cases.
Lai R; Medeiros LJ; Coupland R; McCourty A; Brynes RK
Mod Pathol; 1998 May; 11(5):457-63. PubMed ID: 9619599
[TBL] [Abstract][Full Text] [Related]
12. Expression of glucocorticoid receptors in non-neoplastic lymphoid follicles and B cell type malignant lymphomas.
Okazaki SI; Yamakawa M; Maeda K; Ohta N; Aoyagi M
J Clin Pathol; 2006 Apr; 59(4):410-6. PubMed ID: 16461807
[TBL] [Abstract][Full Text] [Related]
13. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
Miettinen M
Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
[TBL] [Abstract][Full Text] [Related]
14. Immunolocalization of the ICE/Ced-3-family protease, CPP32 (Caspase-3), in non-Hodgkin's lymphomas, chronic lymphocytic leukemias, and reactive lymph nodes.
Krajewski S; Gascoyne RD; Zapata JM; Krajewska M; Kitada S; Chhanabhai M; Horsman D; Berean K; Piro LD; Fugier-Vivier I; Liu YJ; Wang HG; Reed JC
Blood; 1997 May; 89(10):3817-25. PubMed ID: 9160689
[TBL] [Abstract][Full Text] [Related]
15. T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells.
Lim MS; Beaty M; Sorbara L; Cheng RZ; Pittaluga S; Raffeld M; Jaffe ES
Am J Surg Pathol; 2002 Nov; 26(11):1458-66. PubMed ID: 12409722
[TBL] [Abstract][Full Text] [Related]
16. alpha-Naphthyl acetate esterase activity--a cytochemical marker for T lymphocytees. Correlation with immunologic studies of normal tissues, lymphocytic leukemias, non-Hodgkin's lymphomas, Hodgkin's disease, and other lymphoproliferative disorders.
Pinkus GS; Hargreaves HK; McLeod JA; Nadler LM; Rosenthal DS; Said JW
Am J Pathol; 1979 Oct; 97(1):17-41. PubMed ID: 315166
[TBL] [Abstract][Full Text] [Related]
17. Use of monoclonal antibodies for the typing of malignant lymphomas in routinely processed biopsy samples.
Lauritzen AF; Ralfkiaer E
APMIS; 1991 Jul; 99(7):631-9. PubMed ID: 2069805
[TBL] [Abstract][Full Text] [Related]
18. Characterization of expression of protein kinase C isozymes in human B-cell lymphoma: Relationship between its expression and prognosis.
Kamimura K; Hojo H; Abe M
Pathol Int; 2004 Apr; 54(4):224-30. PubMed ID: 15028022
[TBL] [Abstract][Full Text] [Related]
19. Jaw1/LRMP, a germinal centre-associated marker for the immunohistological study of B-cell lymphomas.
Tedoldi S; Paterson JC; Cordell J; Tan SY; Jones M; Manek S; Dei Tos AP; Roberton H; Masir N; Natkunam Y; Pileri SA; Facchetti F; Hansmann ML; Mason DY; Marafioti T
J Pathol; 2006 Aug; 209(4):454-63. PubMed ID: 16739114
[TBL] [Abstract][Full Text] [Related]
20. Three-color flow cytometry in the diagnosis of malignant lymphoma based on the comparative cell morphology of lymphoma cells and reactive lymphocytes.
Ichinohasama R; DeCoteau JF; Myers J; Kadin ME; Sawai T; Ooya K
Leukemia; 1997 Nov; 11(11):1891-903. PubMed ID: 9369423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
